Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxy 10-14: Amoxicillin Duration in Erythema Migrans
NCT03966014Phase 3Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jun 2019
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin in erythema migrans (EM), sponsored by University Medical Centre Ljubljana. Started Jun 2019; status: recruiting.
02
Drugs
amoxicillin
03
Conditions
erythema migrans (EM)
Beyond the preview
Go deeper on NCT03966014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03966014.